Walter Brooks is a Partner at Equinox Group. He holds a B.A. in Economics and an M.S. in Policy Analysis from SUNY at Stony Brook. His expertise is R&D decision support, concentrating on biopharmaceuticals since 1988.

Allan Miller is a Partner at Equinox Group. He received an M.A. and a Ph.D. in Molecular Biology from the University of Cambridge. His focus is on oncology, virology, and patient flow modeling techniques.

David Godolphin is a Partner at Equinox Group. He received an A.B. from Harvard College. He focuses on unmet medical need analysis, forecasting, and drug development strategy.

Kamakshi (Kaycee) Chakrapani received a B.S. in Chemical Engineering from the Institute of Chemical Technology (Formerly UDCT), Mumbai. She also holds a Master’s of Engineering Management degree from the Thayer School of Engineering at Dartmouth College. Her focus is on forecasting, patient flow modeling techniques, and epidemiology.